Merck to buy drug developer Pandion Therapeutics for $1.85 bln

Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%. Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

Reuters | Updated: 25-02-2021 18:14 IST | Created: 25-02-2021 18:09 IST
Merck to buy drug developer Pandion Therapeutics for $1.85 bln
Representative image. Image Credit: Wikimedia

Merck & Co Inc said on Thursday it would buy drug developer Pandion Therapeutics Inc for about $1.85 billion in cash, expanding its portfolio of drugs that target autoimmune diseases.

The $60-per-share deal represents about 134% premium to Pandion's closing price on Wednesday. Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%.

Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. In November, Merck agreed to buy privately-held VelosBio for $2.75 billion to strengthen its cancer drug portfolio as the drugmaker looks to reduce its reliance on its blockbuster cancer therapy Keytruda.

The deal between Merck and Pandion is expected to close in the first half of 2021, the companies said in a joint statement. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

QUOTES-Soccer-Reaction to major European clubs planning for breakaway Super League

Media reports on Sunday said that 12 European clubs, including six from England, have signed up to a breakaway Super League -- a rival competition to UEFAs Champions League. Following are some reactions to the newsEUROPEAN SOCCERS GOVERNING...

JP Nadda asks BJP workers to start 'Apna Booth, Corona Mukt' campaign

By Kumar Gaurav BJP national president JP Nadda on Sunday held a meeting with state party presidents and national office bearers over the surge in COVID-19 cases in the country.In the virtual meeting, he asked party workers to start the Apn...

1,400 to 2,000 beds to be readied for COVID-19 patients in Delhi in two days: Kejriwal

Chief Minister Arvind Kejriwal on Sunday announced that 1,400 to 2,000 beds will be readied for COVID-19 patients in the city in the next two days, as the city grappled with a shortage of oxygen and beds amid a surge in coronavirus cases.He...

Cases filed against two hospitals in Delhi for turning away COVID patients

Cases were registered against two hospitals in Delhi on Sunday for turning away COVID-19 patients, a day after Chief Minister Arvind Kejriwal warned them of strict action if found giving wrong information about availability of beds. Complai...

Give Feedback